Tag Archives: EU

Simbrinza approved in EU to treat patients living with glaucoma

Basel (Switzerland): Alcon, a global leader in eye care and a division of Novartis, on Monday announced that Simbrinza eye drops suspension (brinzolamide 10mg/mL and brimonidine tartrate 2mg/mL) has been approved by the European Commission to decrease elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension, for which monotherapy provides insufficient IOP reduction.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , | Leave a comment

Forxiga (Dapagliflozin) approved in European Union for treatment of type 2 diabetes

London: AstraZeneca and Bristol-Myers Squibb have said the European Commission has approved Forxiga (Dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union (EU).

Posted in NEWS, Pharmaceuticals | Tagged , , , , , , , , , , , , , | Leave a comment